$2.55
1.16% yesterday
Nasdaq, Nov 06, 10:00 pm CET
ISIN
US09061H3075
Symbol
BMRA

Biomerica, Inc. Stock price

$2.55
-0.38 12.97% 1M
-0.75 22.73% 6M
+0.15 6.21% YTD
-0.31 10.71% 1Y
-23.29 90.13% 3Y
-45.45 94.69% 5Y
-4.57 64.17% 10Y
-1.05 29.17% 20Y
Nasdaq, Closing price Thu, Nov 06 2025
-0.03 1.16%

Key metrics

Basic
Market capitalization
$7.3m
Enterprise Value
$4.3m
Net debt
positive
Cash
$3.1m
Shares outstanding
2.8m
Valuation (TTM | estimate)
P/E
negative | -
P/S
1.5 | -
EV/Sales
0.9 | -
EV/FCF
negative
P/B
1.4
Financial Health
Equity Ratio
69.1%
Return on Equity
-121.1%
ROCE
-94.7%
ROIC
-159.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$4.9m | -
EBITDA
$-4.9m | -
EBIT
$-4.9m | -
Net Income
$-3.7m | -
Free Cash Flow
$-2.8m
Growth (TTM | estimate)
Revenue
-11.4% | -
EBITDA
19.3% | -
EBIT
24.9% | -
Net Income
40.6% | -
Free Cash Flow
45.6%
Margin (TTM | estimate)
Gross
13.0%
EBITDA
-99.8% | -
EBIT
-100.0%
Net
-74.8% | -
Free Cash Flow
-56.6%
More
EPS
$-1.4
FCF per Share
$-1.0
Short interest
2.3%
Employees
64
Rev per Employee
$80.0k
Show more

Is Biomerica, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Biomerica, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Biomerica, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Biomerica, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Biomerica, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '25
+/-
%
4.88 4.88
11% 11%
100%
- Direct Costs 4.25 4.25
15% 15%
87%
0.64 0.64
31% 31%
13%
- Selling and Administrative Expenses 4.58 4.58
19% 19%
94%
- Research and Development Expense 0.94 0.94
29% 29%
19%
-4.88 -4.88
19% 19%
-100%
- Depreciation and Amortization 0.01 0.01
98% 98%
0%
EBIT (Operating Income) EBIT -4.89 -4.89
25% 25%
-100%
Net Profit -3.66 -3.66
41% 41%
-75%

In millions USD.

Don't miss a Thing! We will send you all news about Biomerica, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biomerica, Inc. Stock News

Neutral
GlobeNewsWire
about 18 hours ago
IRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic solutions, today announced the expansion of its Contract Development and Manufacturing Organization (CDMO) services to meet accelerating market demand. The Company is enhancing its capabilities to provide greater value and reliability of product development and manu...
Neutral
GlobeNewsWire
22 days ago
- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Trusted Health Care Distributors - Relationship Marks a Key Milestone in Biomerica's Commercialization Strategy
Neutral
GlobeNewsWire
23 days ago
Reported Improved Gross Margin from Contribution from Higher-Margin Product Mix Operating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company's Ongoing Focus on Cost Reduction and Operational Efficiency Earnings per Share $0.00, Compared to a Net Loss of $0.08 per Share in the First Quarter of the Prior Fiscal Year. IRVINE, Calif.
More Biomerica, Inc. News

Company Profile

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.

Head office United States
CEO Zackary Irani
Employees 64
Founded 1971
Website biomerica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today